ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
派格生物醫藥-B
8.830
+0.010
0.11%
手動刷新
成交量:
4,099.26萬
成交額:
3.78億
市值:
34.53億
市盈率:
-13.88
高:
10.480
開:
9.260
低:
8.430
收:
8.820
52周最高:
77.000
52周最低:
7.460
股本:
3.91億
香港流通股本:
2.84億
量比:
1.75
換手率:
14.43%
股息:
- -
股息率:
- -
每股收益(LYR):
-0.636
淨資產收益率:
-82.42%
總資產收益率:
-31.46%
市淨率:
6.65
市盈率(LYR):
-13.88
市銷率:
-770.20
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
派格生物醫藥-B(02565):維培那肽注射液納入2026年第二批參照藥預溝通增補藥品信息公示
智通财经
·
昨天
異動解讀 | 派格生物醫藥-B盤中大漲5.33%,超跌反彈成主因
异动解读
·
昨天
異動解讀|派格生物醫藥-B盤中上漲10.77%,解禁拋壓集中釋放後技術性反彈
行情直击
·
昨天
異動解讀|派格生物醫藥-B盤中下跌15.99%,上市滿周年禁售期全面解禁引發拋壓
行情直击
·
05/27
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02565"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物醫藥-B","latestPrice":8.83,"timestamp":1779955711008,"preClose":8.82,"halted":0,"volume":40992550,"delay":0,"changeRate":0.001133786848072538,"floatShares":284000000,"shares":391000000,"eps":-0.63624451582576,"marketStatus":"未開盤","change":0.01,"latestTime":"05-28 16:08:31","open":9.26,"high":10.48,"low":8.43,"amount":377971383,"amplitude":0.232426,"askPrice":8.83,"askSize":65000,"bidPrice":8.82,"bidSize":40050,"shortable":3,"etf":0,"ttmEps":-0.63624451582576,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1780018200000},"marketStatusCode":0,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":8.82,"openAndCloseTimeList":[[1779931800000,1779940800000],[1779944400000,1779955200000]],"volumeRatio":1.752982,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":284000000,"roa":"-31.46%","roe":"-82.42%","lyrEps":-0.636245,"volumeRatio":1.752982,"shares":391000000,"dividePrice":0,"high":10.48,"amplitude":0.232426,"preClose":8.82,"low":8.43,"week52Low":7.46,"pbRate":"6.65","psRate":"-770.20","week52High":77,"institutionHeld":0,"latestPrice":8.83,"committee":-0.237506,"eps":-0.63624451582576,"divideRate":0,"volume":40992550,"delay":0,"ttmEps":-0.63624451582576,"open":9.26,"prevYearClose":69,"prevWeekClose":12.94,"prevMonthClose":24.64,"prevQuarterClose":58,"fiveDayClose":15.38,"twentyDayClose":26.38,"sixtyDayClose":64.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-05-27","current":-13.89729,"percent":0.869198,"low":-87.782868,"twenty":-73.777626,"median":-61.31588,"eighty":-19.117647,"high":-11.114373,"avg":-52.767999,"sd":24.924517,"marketCap":3449427312},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-27","current":-13.89213,"twenty":-73.777626,"median":-61.31588,"eighty":-19.117647,"marketCap":3449427312}],"updateTime":1779969672392},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638642026","title":"派格生物醫藥-B(02565):維培那肽注射液納入2026年第二批參照藥預溝通增補藥品信息公示","url":"https://stock-news.laohu8.com/highlight/detail?id=2638642026","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638642026?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 18:18","pubTimestamp":1779963488,"startTime":"0","endTime":"0","summary":"智通财经APP讯,派格生物医药-B 发布公告,根据国家医疗保障局于2026年5月27日发布的《关于2026年第二批参照药预沟通增补药品信息的公示》,本公司申报的维培那肽注射液相关材料经反馈后已被确认符合2026年第二批参照药预沟通的申报要求,并已纳入本次增补药品信息公示范围。本次进入增补公示范围,标志着维培那肽注射液在国家医保参照药预沟通相关工作中取得阶段性进展,有助于后续参照药确认、医保准入及支付管理相关工作的有序推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","BK4581","BK1161","399441","02565","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140836570","title":"異動解讀 | 派格生物醫藥-B盤中大漲5.33%,超跌反彈成主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1140836570","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140836570?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 09:33","pubTimestamp":1779931980,"startTime":"0","endTime":"0","summary":"派格生物医药-B今日盘中大涨5.33%,引起了市场的广泛关注。消息面上,该股昨日因上市满一周年,IPO前股东所持股份禁售期全面到期,大量低成本筹码集中解禁,导致股价出现急跌。经历昨日重挫后,今日股价出现技术性超跌反弹。派格生物医药是一家深耕慢病代谢领域的生物科技公司,核心产品为接近商业化阶段的长效GLP-1受体激动剂PB-119,主要用于治疗2型糖尿病及肥胖症等代谢疾病。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184530545","title":"異動解讀|派格生物醫藥-B盤中上漲10.77%,解禁拋壓集中釋放後技術性反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1184530545","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184530545?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 09:31","pubTimestamp":1779931884,"startTime":"0","endTime":"0","summary":"5月28日,派格生物医药-B盘中上涨10.77%,报9.71港元/股,成交额365.18万港元。消息面上,该股昨日恰逢上市满一周年,IPO前股东所持股份禁售期全面到期,大量低成本筹码集中解禁,盘中一度重挫逾15%,股价最低触及8.78港元。派格生物医药是一家深耕慢病代谢领域的生物科技公司,核心产品为接近商业化阶段的长效GLP-1受体激动剂PB-119,主要用于治疗2型糖尿病及肥胖症等代谢疾病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116027974","title":"異動解讀|派格生物醫藥-B盤中下跌15.99%,上市滿周年禁售期全面解禁引發拋壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1116027974","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116027974?lang=zh_tw&edition=fundamental","pubTime":"2026-05-27 09:39","pubTimestamp":1779845942,"startTime":"0","endTime":"0","summary":"5月27日,派格生物医药-B盘中下跌15.99%,报9.29港元/股,成交额4687.47万港元。消息面上,派格生物医药-B于去年5月27日在港交所挂牌上市,今日恰逢上市满一周年,IPO前股东所持股份禁售期全面到期,大量低成本筹码集中解禁。派格生物医药是一家深耕慢病代谢领域的生物科技公司,核心产品为接近商业化阶段的长效GLP-1受体激动剂PB-119,主要用于治疗2型糖尿病及肥胖症等代谢疾病。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":25,"pageCount":1,"totalSize":98,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02565\",params:#limit:6,delay:false,,,undefined,":[]}}